Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

Understanding Clinicians' Perspectives on End-of-Life Dreams and Visions: An International Survey.

Journal of palliative medicine·2026
Same author

AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.

Acta neuropathologica·2026
Same author

Implementation of a Complementary and Integrative Medicine Service on a Palliative Care Unit of a Tertiary Care Center in Switzerland.

Journal of palliative medicine·2026
Same author

A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau.

ACS chemical neuroscience·2026
Same author

Spiritual needs in palliative care inpatients: a four-year analysis of clinical data from a tertiary care center.

BMC palliative care·2026
Same journal

Photobiomodulation to prevent oral mucositis and physical function impairments after hematopoietic cell transplantation: POMFITT randomized trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Evaluating the role of survivorship care plans in modifying disparities in health status among female cancer survivors in Maryland.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Association of social determinants of health and physical functioning among breast cancer survivors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Diagnosis and management of immune checkpoint inhibitor-induced dry mouth and salivary gland dysfunction in oncology patients: a systematic review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Evolving classification systems for cancer cachexia: ready for clinical practice?

David Blum1, Aurelius Omlin, Ken Fearon

  • 1Oncological Palliative Medicine, Division of Oncology/Hematology, Department of Internal Medicine and Palliative Care Center, Cantonal Hospital, Switzerland.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|January 16, 2010
PubMed
Summary
This summary is machine-generated.

This review examines cancer cachexia definitions and classification systems, detailing the development of a new system. It explores pathophysiological mechanisms and treatment options for involuntary weight loss in advanced cancer patients.

Related Experiment Videos

Last Updated: Jun 17, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Area of Science:

  • Oncology
  • Palliative Care
  • Metabolic Research

Background:

  • Involuntary weight loss, a hallmark of cachexia, significantly impacts patients with advanced cancer.
  • Cachexia presents complex challenges in diagnosis and management within oncology settings.

Purpose of the Study:

  • To review current cancer cachexia definitions and classification systems.
  • To describe the development of a novel cancer cachexia classification system.
  • To outline pathophysiological mechanisms and treatment strategies for cancer cachexia.

Main Methods:

  • Comprehensive literature review of existing cachexia definitions and classifications.
  • Delphi process and literature reviews for developing a new classification system.
  • Analysis of pathophysiological mechanisms and current treatment options.

Main Results:

  • Summary of established cachexia classification systems (NCCTG, PG-SGA, Evans et al., Fearon et al., Bozzetti et al.).
  • Presentation of an evolving, literature- and consensus-based new classification system for cancer cachexia.
  • Overview of the pathophysiology and therapeutic interventions for cancer cachexia.

Conclusions:

  • The review highlights the need for updated diagnostic and classification tools for cancer cachexia.
  • A new classification system is under development to aid clinical decision-making.
  • Challenges in clinical decision-making for palliative care in cachexia are discussed.